• Featured Product
  • KD/KO验证

HDAC7 Polyclonal antibody

HDAC7 Polyclonal Antibody for IP, ELISA
Cat No. 26207-1-AP

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human, rat

应用

IP, ELISA and More (1)

HD7, HD7A, HDAC7, HDAC7A, histone deacetylase 7, Histone deacetylase 7A

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive IP detected inK-562 cells

推荐稀释比

应用推荐稀释比
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

26207-1-AP targets HDAC7 in WB, IP, ELISA applications and shows reactivity with human, rat samples.

经测试应用 IP, ELISA Application Description
文献引用应用WB, IP
经测试反应性 human, rat
文献引用反应性human
免疫原 HDAC7 fusion protein Ag24396 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 histone deacetylase 7
别名 HD7, HD7A, HDAC7, HDAC7A, histone deacetylase 7, Histone deacetylase 7A
计算分子量 103 kDa
观测分子量 102 kDa
GenBank蛋白编号BC006453
基因名称 HDAC7
Gene ID (NCBI) 51564
RRIDAB_2880426
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDQ8WUI4
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

实验方案

Product Specific Protocols
IP protocol for HDAC7 antibody 26207-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

发表文章

SpeciesApplicationTitle
humanWB

Int J Biol Sci

Discovery of a novel HDACi structure that inhibits the proliferation of ovarian cancer cells in vivo and in vitro.

Authors - Miao Bai
IP,WB

Cell Biol Int

FBXW7 induces apoptosis in glioblastoma cells by regulating HDAC7.

Authors - Xiaohu Nie
humanWB

J Exp Clin Cancer Res

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway.

Authors - Kai Guo
  • KD Validated
humanWB

Cell Death Dis

AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway

Authors - Liming Deng
Loading...